Amer H. Zureikat, MD, is vice chair of surgery for surgical oncology in the Department of Surgery at UPMC, chief of Surgical Oncology at UPMC Hillman Cancer Center, and UPMC Chair of Clinical Surgery. He is the division chief for gastrointestinal surgical oncology in the Department of Surgery at UPMC and professor of surgery at the University of Pittsburgh School of Medicine. Dr. Zureikat specializes in cancers and diseases of the pancreas, stomach, liver and duodenum and is an expert in robotic pancreatic surgery. His clinical and academic interests include the multimodality treatment of pancreatic cancer, and comparative effectiveness of open and robotic approaches to gastrointestinal cancers in general and pancreatic cancer in particular. Dr. Zureikat is board-certified in general surgery. He received his medical degree from the Royal College of Surgeons in Dublin, Ireland, completed his general surgery residency at the University of Chicago Medical Center and his fellowship in surgical oncology at the University of Pittsburgh/UPMC. Dr. Zureikat is a member of the Society of University Surgeons (SUS), Society of Surgical Oncology (SSO), and the Americas Hepato-Pancreato-Biliary Association (AHPBA). In addition, he is a fellow of the American College of Surgeons (ACS). Dr. Zureikat is rated as an Elite provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Ajay Niranjan, MD, specializes in neurosurgery. He practices at the University of Pittsburgh Physicians, Department of Neurological Surgery and is affiliated with UPMC Presbyterian.  Dr. Niranjan is associate professor of neurological surgery at the University of Pittsburgh School of Medicine. He received his medical degree from King George’s Medical College in Lucknow, India, where he also completed his neurosurgical residency. Dr. Niranjan then completed a fellowship in image-guided neurosurgery at the University of Pittsburgh. A leading expert on stereotactic radiosurgery, Dr. Niranjan has helped develop guidelines for stereotactic radiosurgery for trigeminal neuralgia, pituitary adenomas, arteriovenous malformations, acoustic neuromas, and brain metastases. Dr. Niranjan has co-authored more than 120 articles in journals such as Neurosurgery, Journal of Neurosurgery, and Journal of Neuro-oncology; contributed more than 55 book chapters; and edited two books on stereotactic radiosurgery. Dr. Niranjan is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Schwannoma, Brain Tumor, Metastatic Brain Tumor, Gamma Knife Radiosurgery, and Rhizotomy.

James F. Pingpank Jr., MD, is an associate professor of surgery at the University of Pittsburgh School of Medicine. Dr. Pingpank specializes in regional treatment strategies for advance malignancies of the liver and peritoneal cavity. Dr. Pingpank is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Neuroendocrine Tumor, Liver Embolization, and Hernia Surgery.

Anwaar Saeed, MD, is an Associate Professor of Medicine and the Chief of the Gastrointestinal (GI) Medical Oncology Program at the University of Pittsburgh, University of Pittsburgh Medical Center (UPMC), and UPMC Hillman Cancer Center. She also serves as the Vice Chair of the Colorectal Cancer Committee of the NSABP Foundation. Her research efforts are focused on immune modulatory approaches in patients with gastric & esophageal cancer, colon cancer and hepatocellular carcinoma as well as chemoprevention/ immunoprevention in the high-risk GI population. She has published more than 150 peer reviewed papers, posters and book chapters, and have led more than 40 clinical trials, focused on various immune modulatory regimens including but not limited to immune checkpoint inhibitor combinations with chemotherapy, other checkpoint inhibitors, antibody drug conjugates, bi-specific T cell engagers (BiTE), angiogenesis inhibitors, as well as immunotherapy combinations with regional approaches like stereotactic radiosurgery and intensity-modulated radiation therapy. She currently leads several investigator-initiated trials focused on novel targeted immunotherapy combinations including the ongoing phase I/II CAMILLA multicohort study looking at Cabozantinib plus Durvalumab with or without Tremelimumab in GI malignancies. Results from phase I/II part of the CAMILLA led to the development of the currently ongoing global pivotal trial, STELLAR 303, in patients with previously treated microsatellite stable colorectal cancer. She is also the study chair for a soon to open SWOG/intergroup NCI national trial (S2303) testing a novel chemo-immunotherapy regimen in patients with advanced gastric & esophageal adenocarcinoma. Dr. Saeed is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Stomach Cancer, Cataract Removal, and Gamma Knife Radiosurgery.

Dulabh Monga is an Oncologist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Monga is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Suzanne Schiffman is a Surgical Oncologist and a General Surgeon in Pittsburgh, Pennsylvania. Dr. Schiffman is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Lawrence Lunsford is a Neurosurgery provider in Pittsburgh, Pennsylvania. Dr. Lunsford is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Meningioma, Acoustic Neuroma, Schwannoma, Gamma Knife Radiosurgery, and Rhizotomy.

Kevin J. Contrera, MD, MPH, received his medical degree from Johns Hopkins University School of Medicine. He completed residency in otolaryngology-head and neck surgery at Cleveland Clinic before pursuing fellowships in advanced head & neck surgical oncology and microvascular reconstructive surgery at MD Anderson Cancer Center. Dr. Contrera is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Velopharyngeal Insufficiency, Sinus Cancer, Glossectomy, and Laryngectomy.

Kevin McGrath, MD, specializes in esophageal diseases and disorders and is board-certified by the American Board of Internal Medicine. He practices at UPMC Digestive Health Care at Presbyterian and is affiliated with UPMC McKeesport, UPMC Horizon, UPMC Magee-Womens Hospital, UPMC Shadyside, UPMC Presbyterian, and UPMC Mercy. Dr. McGrath received his medical degree from Thomas Jefferson University Sidney Kimmel Medical College and completed his residency and fellowship at Duke University School of Medicine. Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule. Dr. Mcgrath is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Barrett Esophagus, Endoscopy, and Colonoscopy.

Linwah Yip, MD, FACS, is an associate professor in the Department of Surgery, Division of Endocrine Surgery at the University of Pittsburgh School of Medicine, chief of the Division of Breast and Endocrine Surgery, and program director for the University of Pittsburgh  Endocrine Surgery Fellowship. She specializes in thyroid and parathyroid disease/cancers, adrenal tumors, and functional pancreatic tumors. She studies how molecular testing can optimize diagnosis and treatment for thyroid cancer patients and leads the UPMC VHL Alliance Comprehensive Clinical Care Center. Dr. Yip is board-certified in general surgery. She received her medical degree from the University of Chicago Pritzker School of Medicine, Chicago. Dr. Yip completed surgical residency training at Northwestern University in Chicago and the University of Florida Health Sciences Center in Jacksonville, Fla., and surgical oncology research and clinical fellowships at the University of Texas MD Anderson Cancer Center and UPMC. Dr. Yip is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Thyroid Nodule, Thyroid Cancer, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy.

Kenneth Fasanella, MD, specializes in esophageal diseases and disorders and is board-certified by the American Board of Internal Medicine. He practices at UPMC Digestive Health Care at Presbyterian and is affiliated with UPMC Horizon, UPMC St. Margaret, UPMC Magee-Womens Hospital, UPMC Shadyside, UPMC Presbyterian, and UPMC Mercy. Dr. Fasanella received his medical degree from the University of Virginia School of Medicine. He completed his residency at Duke University School of Medicine and fellowship at the University of Pittsburgh School of Medicine. Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule. Dr. Fasanella is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Jaundice, Barrett Esophagus, Endoscopy, and Pancreatectomy.

Dr. Gardner is the Peter J. Jannetta Endowed Chair of neurological surgery at the University of Pittsburgh School of Medicine and director of the Center for Skull Base Surgery. He specializes in endoscopic endonasal skull base surgery, pituitary tumors, Neuroendoport brain surgery, and vascular neurosurgery. Dr. Gardner is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Chordoma, Pituitary Tumor, Meningioma, Endoscopic Transnasal Transsphenoidal Surgery, and Nerve Decompression.

Jason Luke is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Luke is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Melanoma, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, and Liver Embolization.

Alessandro Paniccia, MD, FACS, is a surgical oncologist and specializes in pancreatic and hepatobiliary surgery. Dr. Paniccia's research interests include pancreatic cancer and hepato-pancreato-biliary (HPB) minimally invasive surgery. Dr. Paniccia is board-certified in general surgery. He received his medical degree from Sapienza University of Rome in Italy. Dr. Paniccia completed residencies in general surgery at Johns Hopkins University in Baltimore and the University of Colorado. He completed a research fellowship at the University of Colorado, followed by a fellowship in complex surgical oncology at UPMC. Dr. Paniccia is a member of the Roman Medical Association, American College of Surgeons, Society of Surgical Oncology, American Medical Association, and American Society of Clinical Oncology. Dr. Paniccia is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma. Dr. Burgess is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Adult Soft Tissue Sarcoma, Merkel Cell Carcinoma, Liposarcoma, Chondrosarcoma, and Gamma Knife Radiosurgery.

John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors. Dr. Rhee is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy.

Matthew Holtzman, MD, is a surgical oncologist specializing in the treatment of colorectal, liver, GI cancers, as well as melanoma and sarcoma. In addition to traditional surgery, Dr. Holtzman specializes in Minimally Invasive surgical approaches to cancer treatment. As part of the David C. Koch Regional Perfusion Cancer Therapy Center, Dr. Holtzman's team performs many specialized concentrated regional chemotherapy and radiotherapy procedures to treat advanced malignancies. His research interests include the treatment of recurrent cancers, regional radiation therapies, and novel treatments for melanoma. Dr. Holtzman is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pseudomyxoma Peritonei, Melanoma, Colorectal Cancer, Splenectomy, and Hernia Surgery.

John M. Kirkwood, MD, is a professor of medicine, dermatology, and clinical and translational science at the University of Pittsburgh School of Medicine and the Clinical and Translational Science Institute at the University of Pittsburgh. Dr. Kirkwood directs the Melanoma Center at UPMC Hillman Cancer Center and specializes in melanoma research and the prevention and early detection of melanoma, as well as the treatment of advanced disease and adjuvant therapy of resectable disease. Dr. Kirkwood is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Uveal Melanoma.

Melissa K. Yee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center.  She specializes in the treatment of solid tumors and blood disorders. Dr. Yee is board-certified by the American Board of Internal Medicine in medical oncology, hematology, and internal medicine.  She received her medical degree from the Drexel University College of Medicine in Philadelphia. She then completed her internal medicine residency and hematology/oncology fellowship at UPMC. She earned her undergraduate degree from Tufts University. After completion of her medical training, she was on staff at Dana Farber Cancer Institute in Boston before returning to Pittsburgh to practice at UPMC Mercy. Dr. Yee is a member of the American Society of Clinical Oncology, American Association for Cancer Research, and American Society of Hematology, and Massachusetts Medical Society. Dr. Yee is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Pleuropulmonary Blastoma.

Harkirat Singh, MD, is a Clinical Assistant Professor at the University of Pittsburgh School of Medicine, and Medical Director of GI Endoscopy at the UPMC Mercy Hospital. Dr.Singh's clinical and research interests include pancreatitis, pancreatic cysts, bile duct strictures, pancreato-biliary endoscopy, gastroenterological malignancies, general gastroenterology and hepatology. In addition to upper endoscopies and colonoscopies, Dr.Singh specializes in advanced endoscopic procedures like endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), endoscopic mucosal resection, and deep enteroscopy. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Colonic Malakoplakia, Bile Duct Stricture, Acute Pancreatitis, Endoscopy, and Gastrectomy.